Rapt Therapeutics Stock Current Asset
| RAPT Stock | USD 30.14 1.04 3.57% |
RAPT Therapeutics' fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting RAPT Stock price.
At this time, RAPT Therapeutics' Non Current Assets Total are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 4.6 M in 2025, whereas Total Current Assets are likely to drop slightly above 158.4 M in 2025. RAPT | Current Asset | Build AI portfolio with RAPT Stock |
RAPT Therapeutics Company Current Asset Analysis
RAPT Therapeutics' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current RAPT Therapeutics Current Asset | 17 K |
Most of RAPT Therapeutics' fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RAPT Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
RAPT Current Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for RAPT Therapeutics is extremely important. It helps to project a fair market value of RAPT Stock properly, considering its historical fundamentals such as Current Asset. Since RAPT Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of RAPT Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of RAPT Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
RAPT Total Assets
Total Assets |
|
In accordance with the recently published financial statements, RAPT Therapeutics has a Current Asset of 17 K. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current asset for all United States stocks is 100.0% higher than that of the company.
RAPT Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RAPT Therapeutics' direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RAPT Therapeutics could also be used in its relative valuation, which is a method of valuing RAPT Therapeutics by comparing valuation metrics of similar companies.RAPT Therapeutics is currently under evaluation in current asset category among its peers.
RAPT Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, RAPT Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to RAPT Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
RAPT Fundamentals
| Return On Equity | -0.78 | ||||
| Return On Asset | -0.46 | ||||
| Current Valuation | 315.47 M | ||||
| Shares Outstanding | 16.54 M | ||||
| Shares Owned By Insiders | 0.42 % | ||||
| Shares Owned By Institutions | 99.58 % | ||||
| Number Of Shares Shorted | 412.05 K | ||||
| Price To Book | 2.93 X | ||||
| Price To Sales | 411.22 X | ||||
| Gross Profit | 1.53 M | ||||
| EBITDA | (126.33 M) | ||||
| Net Income | (129.87 M) | ||||
| Cash And Equivalents | 207.34 M | ||||
| Cash Per Share | 6.99 X | ||||
| Total Debt | 4.49 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 15.97 X | ||||
| Book Value Per Share | 9.94 X | ||||
| Cash Flow From Operations | (83.3 M) | ||||
| Short Ratio | 4.39 X | ||||
| Earnings Per Share | (14.80) X | ||||
| Target Price | 25.83 | ||||
| Number Of Employees | 61 | ||||
| Beta | 0.23 | ||||
| Market Capitalization | 498.45 M | ||||
| Total Asset | 240.32 M | ||||
| Retained Earnings | (614.55 M) | ||||
| Working Capital | 186.88 M | ||||
| Current Asset | 17 K | ||||
| Current Liabilities | 167 K | ||||
| Net Asset | 240.32 M |
About RAPT Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RAPT Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RAPT Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RAPT Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RAPT Stock Analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.